动静脉通路放置与肾功能下降的关联
本研究在瑞典斯德哥尔摩744例透析前患者中比较动静脉通路(AVA)与腹膜透析导管(PDC)术后eGFR下降的差异。结果显示AVA与PDC术后eGFR下降无显著差异,AVA术后eGFR进展快0.26 mL/min/1.73 m2/年(95%CI -0.88至0.35),两种通路均与eGFR下降减缓相关。
要点
- AVA与PDC术后eGFR下降无显著差异,AVA术后进展快0.26 mL/min/1.73 m2/年(95%CI -0.88至0.35)。
- AVA患者术前eGFR更高(8.1 vs 7.0 mL/min/1.73 m2)且下降较慢(-5.6 vs -6.7 mL/min/1.73 m2/年)。
- 两种通路放置后均与eGFR下降减缓相关,透析需求仍是决定通路手术时机的主要因素。
核心结论
- AVA与PDC术后eGFR下降无显著差异,AVA术后eGFR进展快0.26 mL/min/1.73 m2/年(95%CI -0.88至0.35)。
- 两种通路放置均与eGFR下降减缓相关,透析需求仍是决定通路手术时机的主要因素。
研究设计与样本
- 研究为队列研究,纳入2006至2012年瑞典斯德哥尔摩744例透析前患者,其中AVA 435例、PDC 309例。
- 收集术前和术后100天的合并症、用药和实验室数据,随访至透析开始、死亡或100天。
主要发现
- AVA患者术前eGFR为8.1 mL/min/1.73 m2,PDC患者为7.0 mL/min/1.73 m2。
- AVA患者术前eGFR下降速度为-5.6 mL/min/1.73 m2/年,PDC患者为-6.7 mL/min/1.73 m2/年。
- 术后eGFR下降 AVA 较 PDC 快0.26 mL/min/1.73 m2/年(95%CI -0.88至0.35),无显著差异。
临床怎么用
- AVA与PDC术后eGFR下降无显著差异,选择通路类型时可综合考虑其他临床因素。
- 透析需求仍是决定通路手术时机的主要因素,不应仅基于eGFR下降速度决定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is controversial evidence on whether arteriovenous access (AVA) placement may protect renal function and hence should be considered in the timing of access placement. This study aimed to investigate the association between AVA placement and estimated glomerular filtration rate (eGFR) decline as compared with the placement of a peritoneal dialysis catheter (PDC) at a similar time point. METHODS: We studied a cohort of 744 pre-dialysis patients in Stockholm, Sweden, who underwent surgery for AVA or PDC between 2006 and 2012. Data on comorbidity, medication and laboratory measures were collected 100 days before and after surgery. Patients were followed until dialysis start, death or 100 days, whichever came first. The primary outcome was difference in eGFR decline after AVA surgery compared with PDC. Decline in eGFR was estimated through linear mixed models with random intercept and slope, before and after surgery. RESULTS: There were 435 AVA and 309 PDC patients. The AVA patients had higher eGFR (8.1 mL/min/1.73 m2 versus 7.0 mL/min/1.73 m2) and less rapid eGFR decline before surgery (-5.6 mL/min/1.73 m2/year compared with -6.7 mL/min/1.73 m2/year for PDC). We found no difference in eGFR decline after surgery in AVA patients compared with PDC patients [AVA progressed 0.26 (95% confidence interval -0.88 to 0.35) mL/min/1.73 m2/year faster after surgery compared with PDC]. CONCLUSIONS: There was no significant difference in eGFR decline after placement of an AVA compared with a PDC. Both forms of access were associated with reduced eGFR decline in our population. The need for dialysis remains the main determinant for timing of access surgery.
引用
- Hahn Lundström U, Hedin U, Gasparini A, et al. Arteriovenous access placement and renal function decline. Nephrol Dial Transplant. 2021. PMID: 31665436. doi:10.1093/ndt/gfz221
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。